It is important to be aware of potential side effects, the most common are: The most frequently encountered side effect of bremelanotide is nausea (40.0%), which may be intolerable to some people Flushing (20.3%) Injection site reactions (13.2%) Headache (11.3%) Vomiting (4.8%) Who is a good candidate for PT-141
Evidence-based results Better energy, confidence, and overall wellbeing A pathway to sustainable, long-term health Results What patients achieve 0% Reach their weight goals Average weight loss in first three months 0% Report improved energy Patients report sustained energy throughout treatment 0 Week average to first results Most see meaningful changes by week twelve Results That Speak For Themselves Results What patients achieve Your practitioner stays connected throughout your treatment Messaging access to your practitioner Direct line to the doctor who knows your case LEARN MORE Dose adjustments when you need them No waiting rooms, no delays in your care LEARN MORE Community Support Scheduled visits to track progress and refine your plan LEARN MORE
Starting a weight loss journey is exciting
89Bio, which is developing pegozafermin, an investigational glycopegylated FGF21 analog for NASH, saw its stock fall about 16% to $8.21
If you are below that because you haven already started a GLP-1 treatment elsewhere, you just have to give them your starting weight and some sort of documentation of your prior treatment
Prescribing Information: Vivitrol (naltrexone for extended-release injectable suspension)
